87 drugs reach their earliest generic-entry date in 2041

When

Applicant (as listed)

Basis

Jan 2041 · 2

Drug	Ingredient	Applicant	Earliest generic entry	Basis
Erleada NDA 210951 · Tablet · oral · 2 strengths apalutamide	apalutamide	Janssen Biotech	14 Jan 2041 patent, carve-out possible	patent, carve-out possible
Phyrago NDA 216099 · Tablet · oral · 6 strengths dasatinib	dasatinib	Handa Therap	22 Jan 2041 patent	patent

Feb 2041 · 10

Drug	Ingredient	Applicant	Earliest generic entry	Basis
Rezenopy NDA 215487 · Spray · nasal naloxone hydrochloride	naloxone hydrochloride	Scienture	5 Feb 2041 patent	patent
Ozempic NDA 209637 · Solution · subcutaneous · 3 strengths semaglutide	semaglutide	Novo	17 Feb 2041 patent	patent
Wegovy NDA 215256 · Solution · subcutaneous · 10 strengths semaglutide	semaglutide	Novo	17 Feb 2041 patent	patent
Wegovy Hd NDA 215256 · Solution · subcutaneous semaglutide	semaglutide	Novo	17 Feb 2041 patent	patent
Ycanth NDA 212905 · Solution · topical cantharidin	cantharidin	Verrica Pharms	19 Feb 2041 patent	patent
Wayrilz NDA 219685 · Tablet · oral rilzabrutinib	rilzabrutinib	Genzyme Corp	20 Feb 2041 patent	patent
Hetlioz NDA 205677 · Capsule · oral tasimelteon	tasimelteon	Vanda Pharms Inc	21 Feb 2041 patent, carve-out possible	patent, carve-out possible
Hetlioz Lq NDA 214517 · Suspension · oral tasimelteon	tasimelteon	Vanda Pharms Inc	21 Feb 2041 patent, carve-out possible	patent, carve-out possible
Xywav NDA 212690 · Solution · oral calcium oxybate; magnesium oxybate; potassium oxybate; sodium oxybate	calcium oxybate; magnesium oxybate; potassium oxybate; sodium oxybate	Jazz	22 Feb 2041 patent, carve-out possible	patent, carve-out possible
Norliqva NDA 214439 · Solution · oral amlodipine besylate	amlodipine besylate	Cmp Dev Llc	24 Feb 2041 patent	patent

Mar 2041 · 2

Drug	Ingredient	Applicant	Earliest generic entry	Basis
Norepinephrine Bitartrate In 5% Dextrose NDA 214313 · Solution · intravenous · 3 strengths norepinephrine bitartrate	norepinephrine bitartrate	Baxter Hlthcare Corp	8 Mar 2041 patent	patent
Kyzatrex NDA 213953 · Capsule · oral · 2 strengths testosterone undecanoate	testosterone undecanoate	Marius	29 Mar 2041 patent	patent

Apr 2041 · 8

Drug	Ingredient	Applicant	Earliest generic entry	Basis
Abilify Maintena Kit NDA 202971 · For suspension, extended release · intramuscular · 4 strengths aripiprazole	aripiprazole	Otsuka Pharm Co Ltd	1 Apr 2041 patent, carve-out possible	patent, carve-out possible
Evrysdi NDA 213535 · For solution · oral risdiplam	risdiplam	Genentech Inc	15 Apr 2041 patent	patent
Evrysdi NDA 219285 · Tablet · oral risdiplam	risdiplam	Genentech Inc	15 Apr 2041 patent	patent
Xofluza NDA 214410 · For suspension · oral · 3 strengths baloxavir marboxil	baloxavir marboxil	Genentech Inc	21 Apr 2041 patent	patent
Dextenza NDA 208742 · Insert · ophthalmic dexamethasone	dexamethasone	Ocular Therapeutix	26 Apr 2041 patent, carve-out possible	patent, carve-out possible
Tlando NDA 208088 · Capsule · oral testosterone undecanoate	testosterone undecanoate	Verity	28 Apr 2041 patent	patent
Vyleesi (Autoinjector) NDA 210557 · Solution · subcutaneous bremelanotide acetate	bremelanotide acetate	Cosette	29 Apr 2041 patent, carve-out possible	patent, carve-out possible
Cavhanza NDA 217379 · Tablet, orally disintegrating · oral · 2 strengths nilotinib	nilotinib	Cycle	30 Apr 2041 patent	patent

May 2041 · 6

Drug	Ingredient	Applicant	Earliest generic entry	Basis
Opzelura NDA 215309 · Cream · topical ruxolitinib phosphate	ruxolitinib phosphate	Incyte Corp	5 May 2041 patent, carve-out possible	patent, carve-out possible
Zanvastro NDA 220210 · Solution · intrathecal zilganersen sodium	zilganersen sodium	Ionis Pharms Inc	20 May 2041 patent	patent
Eliquis Sprinkle NDA 220073 · For suspension · oral apixaban	apixaban	Bristol	22 May 2041 patent	patent
Epsolay NDA 214510 · Cream · topical benzoyl peroxide	benzoyl peroxide	Mayne Pharma	23 May 2041 patent	patent
Twyneo NDA 214902 · Cream · topical benzoyl peroxide; tretinoin	benzoyl peroxide; tretinoin	Mayne Pharma	23 May 2041 patent	patent
Oxlumo NDA 214103 · Solution · subcutaneous lumasiran sodium	lumasiran sodium	Alnylam Pharms Inc	29 May 2041 patent	patent

Jun 2041 · 3

Drug	Ingredient	Applicant	Earliest generic entry	Basis
Austedo Xr NDA 216354 · Tablet, extended release · oral · 8 strengths deutetrabenazine	deutetrabenazine	Teva	10 Jun 2041 patent	patent
Zimhi NDA 212854 · Solution · intramuscular, subcutaneous naloxone hydrochloride	naloxone hydrochloride	Zmi Pharma	14 Jun 2041 patent	patent
Femlyv NDA 218718 · Tablet, orally disintegrating · oral ethinyl estradiol; norethindrone acetate	ethinyl estradiol; norethindrone acetate	Millicent Mfg Pr	24 Jun 2041 patent	patent

Jul 2041 · 13

Drug	Ingredient	Applicant	Earliest generic entry	Basis
Multrys NDA 209376 · Solution · intravenous cupric sulfate; manganese sulfate; selenious acid; zinc sulfate	cupric sulfate; manganese sulfate; selenious acid; zinc sulfate	Am Regent	1 Jul 2041 patent	patent
Selenious Acid NDA 209379 · Solution · intravenous · 3 strengths selenious acid	selenious acid	Am Regent	1 Jul 2041 patent	patent
Tralement NDA 209376 · Solution · intravenous · 2 strengths cupric sulfate; manganese sulfate; selenious acid; zinc sulfate	cupric sulfate; manganese sulfate; selenious acid; zinc sulfate	Am Regent	1 Jul 2041 patent	patent
Advil Dual Action With Acetaminophen NDA 211733 · Tablet · oral acetaminophen; ibuprofen	acetaminophen; ibuprofen	Haleon Us Holdings	9 Jul 2041 patent	patent
Fabhalta NDA 218276 · Capsule · oral iptacopan hydrochloride	iptacopan hydrochloride	Novartis	15 Jul 2041 patent, carve-out possible	patent, carve-out possible
Acthar Gel NDA 008372 · Injectable · injection corticotropin	corticotropin	Mallinckrodt Ireland	18 Jul 2041 patent, carve-out possible	patent, carve-out possible
Acthar Gel (Autoinjector) NDA 008372 · Injectable · injection · 2 strengths corticotropin	corticotropin	Mallinckrodt Ireland	18 Jul 2041 patent, carve-out possible	patent, carve-out possible
Hernexeos NDA 219042 · Tablet · oral zongertinib	zongertinib	Boehringer Ingelheim	21 Jul 2041 patent	patent
Onyda Xr NDA 217645 · Suspension, extended release · oral clonidine hydrochloride	clonidine hydrochloride	Tris Pharma Inc	28 Jul 2041 patent	patent
Juxtapid NDA 203858 · Capsule · oral · 5 strengths lomitapide mesylate	lomitapide mesylate	Chiesi	29 Jul 2041 patent, carve-out possible	patent, carve-out possible
Qulipta NDA 215206 · Tablet · oral atogepant	atogepant	Abbvie	29 Jul 2041 patent, carve-out possible	patent, carve-out possible
Aqvesme NDA 216196 · Tablet · oral mitapivat sulfate	mitapivat sulfate	Agios Pharms Inc	31 Jul 2041 patent, carve-out possible	patent, carve-out possible
Pyrukynd NDA 216196 · Tablet · oral · 3 strengths mitapivat sulfate	mitapivat sulfate	Agios Pharms Inc	31 Jul 2041 patent, carve-out possible	patent, carve-out possible

Aug 2041 · 4

Drug	Ingredient	Applicant	Earliest generic entry	Basis
Lazcluze NDA 219008 · Tablet · oral · 2 strengths lazertinib mesylate	lazertinib mesylate	Janssen Biotech	1 Aug 2041 patent, carve-out possible	patent, carve-out possible
Qvar Redihaler NDA 207921 · Aerosol, metered · inhalation · 2 strengths beclomethasone dipropionate	beclomethasone dipropionate	Norton Waterford	19 Aug 2041 patent	patent
Sunlenca NDA 215974 · Tablet · oral lenacapavir sodium	lenacapavir sodium	Gilead Sciences Inc	28 Aug 2041 patent, carve-out possible	patent, carve-out possible
Sunlenca NDA 215973 · Solution · subcutaneous lenacapavir sodium	lenacapavir sodium	Gilead Sciences Inc	28 Aug 2041 patent, carve-out possible	patent, carve-out possible

Sep 2041 · 4

Drug	Ingredient	Applicant	Earliest generic entry	Basis
Detectnet NDA 213227 · Solution · intravenous copper cu-64 dotatate	copper cu-64 dotatate	Curium	3 Sep 2041 patent	patent
Mavenclad NDA 022561 · Tablet · oral cladribine	cladribine	Emd Serono Inc	10 Sep 2041 patent, carve-out possible	patent, carve-out possible
Jaypirca NDA 216059 · Tablet · oral · 2 strengths pirtobrutinib	pirtobrutinib	Loxo Oncol	14 Sep 2041 patent	patent
Pluvicto NDA 215833 · Solution · intravenous lutetium lu-177 vipivotide tetraxetan	lutetium lu-177 vipivotide tetraxetan	Novartis	18 Sep 2041 patent, carve-out possible	patent, carve-out possible

Oct 2041 · 11

Drug	Ingredient	Applicant	Earliest generic entry	Basis
Farxiga NDA 202293 · Tablet · oral dapagliflozin	dapagliflozin	Astrazeneca Ab	1 Oct 2041 patent	patent
Brenzavvy NDA 214373 · Tablet · oral bexagliflozin	bexagliflozin	Theracosbio	5 Oct 2041 patent	patent
Arbli NDA 218772 · Suspension · oral losartan potassium	losartan potassium	Scienture	7 Oct 2041 patent	patent
Atzumi NDA 217901 · Powder · nasal dihydroergotamine mesylate	dihydroergotamine mesylate	Satsuma Pharms	12 Oct 2041 patent	patent
Potassium Phosphates In 0.9% Sodium Chloride NDA 212832 · Solution · intravenous · 2 strengths potassium phosphate, dibasic; potassium phosphate, monobasic	potassium phosphate, dibasic; potassium phosphate, monobasic	Fresenius Kabi Usa	12 Oct 2041 patent	patent
Potassium Phosphates In 0.9% Sodium Chloride NDA 218343 · Solution · intravenous potassium phosphate, dibasic; potassium phosphate, monobasic	potassium phosphate, dibasic; potassium phosphate, monobasic	Amneal	12 Oct 2041 patent	patent
Litfulo NDA 215830 · Capsule · oral ritlecitinib tosylate	ritlecitinib tosylate	Pfizer	17 Oct 2041 patent	patent
Etcamah NDA 220359 · Tablet · oral camizestrant	camizestrant	Astrazeneca	22 Oct 2041 patent	patent
Lynparza NDA 208558 · Tablet · oral · 2 strengths olaparib	olaparib	Astrazeneca	25 Oct 2041 patent, carve-out possible	patent, carve-out possible
Kyprolis NDA 202714 · Powder · intravenous · 3 strengths carfilzomib	carfilzomib	Onyx Pharms Amgen	29 Oct 2041 patent	patent
Paxlovid (Copackaged) NDA 217188 · Tablet · oral nirmatrelvir; ritonavir	nirmatrelvir; ritonavir	Pfizer	31 Oct 2041 patent, carve-out possible	patent, carve-out possible

Nov 2041 · 8

Drug	Ingredient	Applicant	Earliest generic entry	Basis
Bylvay NDA 215498 · Capsule · oral / Capsule, pellets · oral · 4 strengths odevixibat	odevixibat	Ipsen	12 Nov 2041 patent, carve-out possible	patent, carve-out possible
Lybalvi NDA 213378 · Tablet · oral · 4 strengths olanzapine; samidorphan l-malate	olanzapine; samidorphan l-malate	Alkermes Inc	12 Nov 2041 patent	patent
Radicava Ors NDA 215446 · Suspension · oral edaravone	edaravone	Shionogi	12 Nov 2041 patent, carve-out possible	patent, carve-out possible
Icotyde NDA 220149 · Tablet · oral icotrokinra hydrochloride	icotrokinra hydrochloride	Janssen Biotech	19 Nov 2041 patent	patent
Miplyffa NDA 214927 · Capsule · oral · 4 strengths arimoclomol citrate	arimoclomol citrate	Zevra Denmark	19 Nov 2041 patent	patent
Invega Hafyera NDA 207946 · Suspension, extended release · intramuscular · 2 strengths paliperidone palmitate	paliperidone palmitate	Janssen Pharms	24 Nov 2041 patent, carve-out possible	patent, carve-out possible
Posluma NDA 216023 · Solution · intravenous flotufolastat f-18 gallium	flotufolastat f-18 gallium	Blue Earth	27 Nov 2041 patent	patent
Veklury NDA 214787 · Powder · intravenous remdesivir	remdesivir	Gilead Sciences Inc	28 Nov 2041 patent	patent

Dec 2041 · 16

Drug	Ingredient	Applicant	Earliest generic entry	Basis
Solosec NDA 209363 · Granule · oral secnidazole	secnidazole	Evofem Inc	11 Dec 2041 patent, carve-out possible	patent, carve-out possible
Opipza NDA 216655 · Film · oral · 3 strengths aripiprazole	aripiprazole	Xiamen Lp Pharm Co	15 Dec 2041 patent	patent
Crexont NDA 217186 · Capsule, extended release · oral · 4 strengths carbidopa; levodopa	carbidopa; levodopa	Impax	21 Dec 2041 patent, carve-out possible	patent, carve-out possible
Eligard Kit NDA 021379 · Powder · subcutaneous leuprolide acetate	leuprolide acetate	Tolmar	22 Dec 2041 patent	patent
Eligard Kit NDA 021343 · Powder · subcutaneous leuprolide acetate	leuprolide acetate	Tolmar	22 Dec 2041 patent	patent
Eligard Kit NDA 021731 · Powder · subcutaneous leuprolide acetate	leuprolide acetate	Tolmar	22 Dec 2041 patent	patent
Eligard Kit NDA 021488 · Powder · subcutaneous leuprolide acetate	leuprolide acetate	Tolmar	22 Dec 2041 patent	patent
Fensolvi Kit NDA 213150 · Powder · subcutaneous leuprolide acetate	leuprolide acetate	Tolmar	22 Dec 2041 patent	patent
Lifyorli (Copackaged) NDA 220641 · Capsule · oral relacorilant	relacorilant	Corcept Therap	22 Dec 2041 patent	patent
Ubrelvy NDA 211765 · Tablet · oral · 2 strengths ubrogepant	ubrogepant	Abbvie	22 Dec 2041 patent, carve-out possible	patent, carve-out possible
Xromi NDA 216593 · Solution · oral hydroxyurea	hydroxyurea	Nova Labs Ltd	23 Dec 2041 patent	patent
Aphexda NDA 217159 · Powder · subcutaneous motixafortide acetate	motixafortide acetate	Ayrmid Pharma	29 Dec 2041 patent	patent
Bynfezia Pen NDA 213224 · Solution · subcutaneous octreotide acetate	octreotide acetate	Sun Pharm	29 Dec 2041 patent, carve-out possible	patent, carve-out possible
Mounjaro NDA 215866 · Solution · subcutaneous · 12 strengths tirzepatide	tirzepatide	Eli Lilly And Co	30 Dec 2041 patent, carve-out possible	patent, carve-out possible
Mounjaro (Autoinjector) NDA 215866 · Solution · subcutaneous · 6 strengths tirzepatide	tirzepatide	Eli Lilly And Co	30 Dec 2041 patent, carve-out possible	patent, carve-out possible
Mounjaro Kwikpen NDA 215866 · Solution · subcutaneous · 6 strengths tirzepatide	tirzepatide	Eli Lilly And Co	30 Dec 2041 patent, carve-out possible	patent, carve-out possible